Quetiapine Fumarate
Product Images NDC 64725-8166

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 64725-8166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 8166)

A repackaged label for Quetiapine Fumarate 50 mg tablets in a 100-count bottle by TYA Pharmaceuticals. It includes the original manufacturer name as Teva, the lot number and expiration date placeholders, contact information for TYA Pharmaceuticals in Tallahassee, FL, a barcode, and a note to see the package insert for dosage instructions.*

FDA Label Image

Quetiapine Fumarate Structural Formula (8bd44d47 53c8 4e20 B827 Dbca04bcc3f7 01)

Chemical structure of the active ingredient quetiapine fumarate, depicting molecular components including a dibenzothiazepine core and a fumarate molecule.*

FDA Label Image

Figure 1 (8bd44d47 53c8 4e20 B827 Dbca04bcc3f7 02)

A Kaplan-Meier survival curve chart showing the proportion of patients with relapse (%) on the y-axis and time in weeks on the x-axis. The chart compares two groups: QTP+ LI/VAL (dashed line) and PLA+ LI/VAL (solid line), depicting relapse rates over a period of around 90 weeks.*

FDA Label Image

Figure 2 (8bd44d47 53c8 4e20 B827 Dbca04bcc3f7 03)

A line graph showing the proportion of patients with relapse (%) over time (weeks). Two groups are compared: QTP+ LI/VAL with a dashed line, and PLA+ LI/VAL with a solid line. The graph illustrates changes in relapse rates in patients over a period of up to 100 weeks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.